Literature DB >> 25270515

Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study.

Khalid Al-Rubeaan1, Ahmed M Abu El-Asrar, Amira M Youssef, Shazia N Subhani, Najlaa A Ahmad, Ahmad H Al-Sharqawi, Abdullah Alguwaihes, Metib S Alotaibi, Ali Al-Ghamdi, Heba M Ibrahim.   

Abstract

PURPOSE: To assess diabetic retinopathy prevalence and its risk factors in a society with type 2 diabetes epidemic using the Saudi National Diabetes Registry (SNDR).
METHOD: This is a cross-sectional study using patient's clinical data found in SNDR data base. A cohort of 50,464 Saudi patients with type 2 diabetes aged ≥25 years were selected to assess for the prevalence and risk factors for diabetic retinopathy.
RESULTS: The overall prevalence of diabetic retinopathy is 19.7%, where 9.1% have non-proliferative diabetic retinopathy (NPDR), 10.6% have proliferative diabetic retinopathy (PDR) and 5.7% have macular oedema (ME). Duration of diabetes and age are the most significant risk factors for diabetic retinopathy with odds ratio (OR) and 95% confidence interval (95% CI) 8.88 (8.30-9.50) and 5.76 (5.10-6.55), respectively. Nephropathy, neuropathy, insulin use, poor glycemic control, hypertension and male gender significantly increased the risk for diabetic retinopathy. Smoking, hyperlipidemia and obesity significantly reduced the risk for diabetic retinopathy among type 2 Saudi diabetic cohort.
CONCLUSION: vThe low prevalence of diabetic retinopathy in our registry may be a result of the shortage or absence of well-structured screening programmes. Therefore, many patients with NPDR might have been missed. A prevention programme is needed to reduce the effect of diabetic retinopathy risk factors in this society.
© 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Saudi National Diabetes Registry; diabetic retinopathy; macular oedema; non-proliferative diabetic retinopathy; proliferative diabetic retinopathy; risk factors

Mesh:

Year:  2014        PMID: 25270515     DOI: 10.1111/aos.12532

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  36 in total

1.  Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.

Authors:  E Al Kahtani; Z Xu; S Al Rashaed; L Wu; A Mahale; J Tian; E B Abboud; N G Ghazi; I Kozak; V Gupta; J F Arevalo; E J Duh
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

2.  Visual impairment and associated risk factors in patients with diabetes mellitus in Tavush and Armavir provinces of Armenia.

Authors:  Aida Giloyan; Diana Muradyan; Vahe Khachadourian
Journal:  Int Ophthalmol       Date:  2021-08-11       Impact factor: 2.031

3.  Prevalence of and risk factors for diabetic macular edema in a northeastern Chinese population.

Authors:  Zhong Lin; Feng-Hua Wang; Liang Wen; Yu Wang; Dong Li; Xiao-Xia Ding; Yu Dou; Gang Zhai; Yuan-Bo Liang
Journal:  Int J Ophthalmol       Date:  2022-02-18       Impact factor: 1.779

Review 4.  Diabetes epidemic sweeping the Arab world.

Authors:  Bisher Abuyassin; Ismail Laher
Journal:  World J Diabetes       Date:  2016-04-25

5.  Diabetes Onset at 31-45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes.

Authors:  Wenjun Zou; Lisha Ni; Qianyi Lu; Chen Zou; Minjie Zhao; Xun Xu; Haibing Chen; Zhi Zheng
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

6.  Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes.

Authors:  Jianbo Pan; Sheng Liu; Michael Farkas; Mark Consugar; Donald J Zack; Igor Kozak; J Fernando Arevalo; Eric Pierce; Jiang Qian; Eman Al Kahtani
Journal:  Mol Vis       Date:  2016-06-11       Impact factor: 2.367

7.  Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates.

Authors:  Herbert F Jelinek; Wael M Osman; Ahsan H Khandoker; Kinda Khalaf; Sungmun Lee; Wael Almahmeed; Habiba S Alsafar
Journal:  BMJ Open Diabetes Res Care       Date:  2017-08-08

8.  Awareness of diabetic retinopathy among people with diabetes in Jeddah, Saudi Arabia.

Authors:  Sami H Alzahrani; Marwan A Bakarman; Saleh M Alqahtani; Maha S Alqahtani; Nadeem Shafique Butt; Emad M Salawati; Ahmad Alkatheri; Ahmad Azam Malik; Khaled Saad
Journal:  Ther Adv Endocrinol Metab       Date:  2018-03-04       Impact factor: 3.565

9.  Obesity and diabetic retinopathy: What is the association?

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2015

Review 10.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.